Drug Profile


Alternative Names: Aidfarel; Binary Molecular DNA Clamp (BMC)

Latest Information Update: 16 Feb 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PAMBEC Laboratories
  • Class
  • Mechanism of Action HIV replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported HIV infections

Most Recent Events

  • 16 Feb 2006 No development reported - Preclinical for HIV infections treatment in USA (IV-injection)
  • 02 Dec 2004 This compound is still in active development for HIV infections treatment
  • 12 Dec 2001 Preclinical development for HIV infections treatment in USA (IV-injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top